Elicera Therapeutics AB (publ) announced that representatives of the largest owners have appointed the nomination committee ahead of the Annual General Meeting 2023. On March 7, the Annual General Meeting established rules to guide the work of the Nomination Committee. The three largest owners on September 30, 2022, were Magnus Essand, Di Yu and Jamal El-Mosleh, who together control 47.1% of the votes, and will be the election committee with Magnus Essand as chairman.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 SEK | +8.47% | +31.69% | -71.93% |
29/05 | Elicera Therapeutics Set to Begin First Clinical CAR T-Cell study CARMA | CI |
27/05 | Elicera Therapeutics AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-71.93% | 4.26M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- ELIC Stock
- News Elicera Therapeutics AB
- Elicera Therapeutics AB Announces Appointment of Nomination Committee